International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9168 - 9168
Published: Aug. 23, 2024
The
healthy
cervicovaginal
microbiota
is
dominated
by
various
Lactobacillus
species,
which
support
a
condition
of
eubiosis.
Among
their
many
functions,
vaginal
lactobacilli
contribute
to
the
maintenance
an
acidic
pH,
produce
antimicrobial
compounds,
and
modulate
host
immune
response
protect
against
bacterial
fungal
infections.
Increasing
evidence
suggests
that
these
beneficial
bacteria
may
also
confer
protection
sexually
transmitted
infections
(STIs)
caused
viruses
such
as
human
papillomavirus
(HPV),
immunodeficiency
virus
(HIV)
herpes
simplex
(HSV).
Viral
STIs
pose
substantial
public
health
burden
globally,
causing
range
infectious
diseases
with
potentially
severe
consequences.
Understanding
molecular
mechanisms
exert
protective
effects
viral
paramount
for
development
novel
preventive
therapeutic
strategies.
This
review
aims
provide
more
recent
insights
into
intricate
interactions
between
STIs,
exploring
impact
on
microenvironment,
response,
infectivity
pathogenesis,
highlighting
potential
implications
interventions
clinical
management
Foods,
Journal Year:
2024,
Volume and Issue:
13(23), P. 3886 - 3886
Published: Dec. 1, 2024
Foodborne
pathogens
are
microorganisms
that
cause
illness
through
contamination,
presenting
significant
risks
to
public
health
and
food
safety.
This
review
explores
the
metabolites
produced
by
these
pathogens,
including
toxins
secondary
metabolites,
their
implications
for
human
health,
particularly
concerning
cancer
risk.
We
examine
various
such
as
Salmonella
sp.,
Campylobacter
Escherichia
coli,
Listeria
monocytogenes,
detailing
specific
of
concern
carcinogenic
mechanisms.
study
discusses
analytical
techniques
detecting
chromatography,
spectrometry,
immunoassays,
along
with
challenges
associated
detection.
covers
effective
control
strategies,
processing
techniques,
sanitation
practices,
regulatory
measures,
emerging
technologies
in
pathogen
control.
manuscript
considers
broader
highlighting
importance
robust
policies,
awareness,
education.
identifies
research
gaps
innovative
approaches,
recommending
advancements
detection
methods,
preventive
policy
improvements
better
manage
foodborne
metabolites.
Foods,
Journal Year:
2024,
Volume and Issue:
13(15), P. 2386 - 2386
Published: July 28, 2024
Fermented
foods
can
provide
many
benefits
to
our
health.
These
are
created
by
the
action
of
microorganisms
and
help
support
digestive
health
immune
system.
include
yogurt,
Probiotics and Antimicrobial Proteins,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 8, 2024
Abstract
Probiotics
are
pivotal
in
maintaining
or
restoring
the
balance
of
human
intestinal
microbiota,
a
crucial
factor
mitigating
diseases
and
preserving
host’s
health.
Exploration
into
Bacteroides
spp.
reveals
substantial
promise
their
development
as
next-generation
probiotics
due
to
profound
interaction
with
host
immune
cells
capability
regulate
microbiome’s
metabolism
by
significantly
impacting
metabolite
production.
These
beneficial
bacteria
exhibit
potential
ameliorating
various
health
issues
such
disorders,
cardiovascular
diseases,
behavioral
even
cancer.
Though
it’s
important
note
that
high
percentage
them
well
opportunistic
pathogens,
posing
risks
under
certain
conditions.
Studies
highlight
role
modifying
responses
improving
conditions
regulating
lymphocytes,
controlling
metabolism,
preventing
inflammation
The
safety
efficacy
strains
currently
scrutiny
European
Commission
for
authorization
food
processing,
marking
significant
step
towards
commercialization.
recent
advancements
bacterial
isolation
sequencing
methodologies,
coupled
integration
Metagenome-Assembled
Genomes
(MAGs)
binning
from
metagenomics
data,
continue
unveil
spp.,
aiding
broader
understanding
application
these
novel
disease
management.
Frontiers in Drug Discovery,
Journal Year:
2024,
Volume and Issue:
4
Published: July 17, 2024
Antimicrobial
Resistance
(AMR)
is
a
critical
global
health
challenge,
and
in
this
review
article,
we
examine
the
limitations
of
traditional
therapeutic
methods
emerging
role
alternative
therapies.
By
examining
reasons
behind
failure
conventional
treatments,
including
inadequacy
one-drug-one-enzyme
approaches,
complex
evolution
AMR,
impact
drug
biotransformation,
better
understand
why
treatments
failed.
Moreover,
discusses
several
therapies,
RNA-based
aptamers,
peptide-based
phage
therapy,
probiotics,
discussing
their
applications,
advantages,
limitations.
Additionally,
discuss
obstacles
to
develop
these
funding
shortages,
regulatory
barriers,
public
perception.
This
comprehensive
analysis
aims
provide
insight
into
future
emphasizing
need
for
innovative
strategies
practical
approaches.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 16, 2025
Clostridioides
difficile
is
a
major
cause
of
nosocomial
diarrhea.
As
current
antibiotic
treatment
failures
and
recurrence
infections
are
highly
frequent,
alternative
strategies
needed
for
the
this
disease.
This
study
explores
use
bacteriocins,
specifically
lacticin
3147
pediocin
PA-1,
which
have
reported
inhibitory
activity
against
C.
difficile.
We
engineered
Lactococcus
lactis
strains
to
produce
these
bacteriocins
individually
or
in
combination,
aiming
enhance
their
Our
results
show
that
PA-1
display
synergy,
resulting
higher
anti-C.
activity.
then
evaluated
effects
L.
Simplified
Human
Intestinal
Microbiome
(SIHUMI-C)
model,
bacterial
consortium
eight
diverse
human
gut
species
includes
After
introducing
bacteriocin-producing
into
SIHUMI-C,
samples
were
collected
over
24
hours,
genome
copies
each
assessed
using
qPCR.
Contrary
expectations,
combined
increased
levels
despite
showing
synergy
agar-based
screening.
can
be
rationally
explained
by
antagonistic
inter-species
interactions
within
providing
new
insights
how
broad-spectrum
antimicrobials
might
fail
control
targeted
complex
microbial
communities.
These
findings
highlight
need
mitigate
off-target
microbiomes
when
developing
bacteriocin-based
therapies
with
potential
clinical
implications
infectious
disease
treatment.
World Journal of Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
15(2)
Published: April 11, 2025
The
gut
microbiome,
a
complex
ecosystem
of
microorganisms,
has
significant
role
in
modulating
pain,
particularly
within
orthopaedic
conditions.
Its
impact
on
immune
and
neurological
functions
is
underscored
by
the
gut-brain
axis,
which
influences
inflammation,
pain
perception,
systemic
responses.
This
integrative
review
examines
current
research
how
dysbiosis
associated
with
various
pathways,
notably
nociceptive
neuroinflammatory
mechanisms
linked
to
central
sensitization.
We
highlight
advancements
meta-omics
technologies,
such
as
metagenomics
metaproteomics,
deepen
our
understanding
microbiome-host
interactions
their
implications
pain.
Recent
studies
emphasize
that
gut-derived
short-chain
fatty
acids
microbial
metabolites
play
roles
neuroinflammation
nociception,
contributing
management.
Probiotics,
prebiotics,
synbiotics,
faecal
microbiome
transplants
are
explored
potential
therapeutic
strategies
alleviate
through
modulation,
offering
an
adjunct
or
alternative
opioids.
However,
variability
individual
microbiomes
poses
challenges
standardizing
these
treatments,
necessitating
further
rigorous
clinical
trials.
A
multidisciplinary
approach
combining
microbiology,
immunology,
neurology,
orthopaedics
essential
develop
innovative,
personalized
management
rooted
health,
transform
care.